Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Changwei Pharmaceutical, a core subsidiary of the Chengdu Rongyao Group, is a comprehensive pharmaceutical enterprise based in Sichuan, China, specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicines. The company operates large-scale production facilities that comply with national GMP standards, producing a wide range of finished dosage forms including tablets, capsules, and granules. Its product portfolio primarily focuses on anti-infectives, gastrointestinal treatments, and cardiovascular health, serving both domestic and international markets. Sichuan Changwei Pharmaceutical is recognized for its integration of modern pharmaceutical technology with traditional medicinal practices to provide high-quality healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Rongyao Group Sichuan Changwei Pharmaceutical.